NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 3 February 2010 A study has shown that, in older community-dwelling women, a simple model based on age and bone mineral density alone (BMD), such as that recommended by […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 3 February 2010 The Department of Health has published an economic evaluation which models the costs and benefits from establishing a fracture prevention service to reduce the risk of […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 9 November 2009 This meta-analysis found that high-dose vitamin D supplements reduced the relative risk of falling by 19% in individuals aged 65 years or more. Eleven people would […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 September 2009 This analysis of data from the FIT study found that measuring bone mineral density in postmenopausal women taking alendronate produces unreliable results. Early routine monitoring should […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20th March 2009 Among the elderly, the greatest risk of fracture comes from falls, not osteoporosis. Bone mineral density measurement may be imprecise and it should not be used […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. NICE. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate▼ for the primary prevention of osteoporotic fragility fractures in postmenopausal women. Technology appraisal 160. October 2008 NICE. Alendronate, etidronate, risedronate, raloxifene, […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Sørensen HT, Christensen S, Mehnert F, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ, 2008;336:813-6 May 14th 2008 […]